OP0137 Assessing the risk of ra patients for comorbid conditions through a structured nurse-led interview – the eriko study
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.1268
Abstract: Background Assessment of comorbidities in rheumatoid arthritis (RA) has proven to be difficult for the rheumatologist due to lack of time leading to considerable deficits. Nurse-led programs on RA comorbidity management might solve this problem… read more here.
Keywords: gmbh; deutschland gmbh; risk; abbvie deutschland ... See more keywords
THU0339 PULMONARY INVOLVEMENT AND OUTCOME IN SYSTEMIC SCLEROSIS (SSC) – ILD-PH AS AN IMPORTANT SUBSET
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.1775
Abstract: Background Pulmonary involvement is the leading cause of death in SSc and can manifest as interstitial lung disease (ILD), pulmonary hypertension (PAH) or a combination (ILD-PH). Aim of this analysis was to determine prevalence, clinical… read more here.
Keywords: speakers bureau; roche; none declared; gmbh ... See more keywords
OP0182 PROTEOGLYCAN LOSS IN ARTICULAR CARTILAGE IS ASSOCIATED WITH JOINT INFLAMMATION SEVERITY IN PSORIATIC ARTHRITIS – A COMPOSITIONAL MAGNETIC RESONANCE IMAGING STUDY
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.5557
Abstract: Even though cartilage loss is a known feature of psoriatic arthritis (PsA), little is known about its role in the pathogenesis of PsA. Using delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) as a non-invasive… read more here.
Keywords: none declared; pharma; deutschland gmbh; gmbh ... See more keywords
THU0476 GLYCOSAMINOGLYCAN REMODELLING OF LUMBAR INTERVERTEBRAL DISCS IN ELITE ROWERS THROUGHOUT THEIR ANNUAL TRAINING CYCLE
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.6453
Abstract: To assess the glycosaminoglycan (GAG) content of lumbar intervertebral discs (IVD) in elite rowers (ER) at different stages of their annual training cycle and compared to healthy volunteers (HV) using GAG chemical exchange saturation transfer… read more here.
Keywords: pharma gmbh; deutschland gmbh; training cycle; gmbh ... See more keywords
EP1184 Tissue engineered autologous oral mucosa as an innovative procedure for reconstruction surgery in patients with vaginal or vulvar malignancies
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-esgo.1223
Abstract: Introduction/Background Premalignant or malignant disease of the vulva or vagina and require appropriate surgical oncological treatment. In these patients, wound breakdown occurs in 20–40% and, additionally, some patients might not be eligible for standard procedures… read more here.
Keywords: oral mucosa; membrane; gmbh; tissue engineered ... See more keywords
Initiating Basal Insulin Supported Oral Therapy (BOT) with Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control in Patients (Pts) with Type 2 Diabetes (T2DM) without Increasing Hypoglycemia Risk
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1027-p
Abstract: Toujeo-1, a prospective observational study, investigates the effects of initiating BOT with Gla-300 in insulin-naive pts with T2DM in Germany (n=1,680) and Switzerland, insufficiently controlled (A1c 7.5-10%) on oral antidiabetic drugs (OADs) in daily clinical… read more here.
Keywords: insulin; advisory panel; gmbh; self ... See more keywords